drugset / Trial / NCT06088472
TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors
Phase 1
Recruiting
12 enrolled
Grit Biotechnology
The Affiliated Hospital of Xuzhou Medical University · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, single-arm phase I clinical trial.The study process was divided into: screening period, sampling and production period, NMA-LD chemotherapy , treatment and observation period, and follow-up period.
Timeline
- Start
- 2021-04-21
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TIL injection | Cell therapy | — | — |
Indications
No indication recorded.